Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent progress in mite allergen immunochemistry.

P W Heymann1, M D Chapman

  • 1Division of Allergy and Clinical Immunology, University of Virginia Medical Center, Charlottesville 22908.

Clinical Reviews in Allergy
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laboratory biomarkers associated with COVID-19 severity and management.

Clinical immunology (Orlando, Fla.)·2020
Same author

Serological, genomic and structural analyses of the major mite allergen Der p 23.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2015
Same author

Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2015
Same author

Infection with human rhinovirus 16 promotes enhanced IgE responsiveness in basophils of atopic asthmatics.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
Same author

Sensitization to food and inhalant allergens in relation to age and wheeze among children with atopic dermatitis.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2013
Same author

International consensus on (ICON) pediatric asthma.

Allergy·2012
Same journal

Leukotriene and thromboxane antagonists.

Clinical reviews in allergy·1994
Same journal

The role of food in the pathogenesis of migraine headache.

Clinical reviews in allergy·1994
See all related articles

Researchers have developed new monoclonal antibody (Mab) immunoassays for accurately measuring mite allergens in dust. This advancement aids in understanding allergic responses and monitoring allergen avoidance strategies for improved patient health.

Area of Science:

  • Immunochemistry
  • Allergen research
  • Molecular immunology

Background:

  • Mite allergens are key triggers for allergic diseases like asthma and rhinitis.
  • Understanding mite allergen immunochemistry is crucial for developing effective diagnostics and therapies.
  • Previous methods for quantifying dust mite allergens were limited.

Purpose of the Study:

  • To develop sensitive and quantitative methods for measuring mite allergen levels in dust.
  • To facilitate objective monitoring of allergen avoidance strategies.
  • To improve the standardization of allergen extracts for diagnosis and treatment.

Main Methods:

  • Purification of mite allergens.
  • Production of murine monoclonal antibodies (Mabs) against mite allergens.

Related Experiment Videos

  • Development of Mab-based immunoassays (radio- or enzyme-labeled).
  • Amino acid sequencing and peptide fragment identification.

    • Main Results:

    • Purified allergens enabled detailed immunochemical studies and Mab production.
    • Mab immunoassays provide rapid, quantitative measurements of specific mite allergens.
    • These assays allow objective monitoring of allergen avoidance effectiveness.
    • Improved standardization of allergen extracts for clinical use.

    Conclusions:

    • Monoclonal antibody immunoassays represent a significant advancement in quantifying mite allergens.
    • These assays offer valuable clinical information on patient exposure and treatment efficacy.
    • The developed methods will enhance allergen standardization and immunotherapy.